C286, an orally available retinoic acid receptor ß agonist drug, regulates multiple pathways to achieve spinal cord injury repair. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fnmol.2024.1411384
PubMed Identifier: 39228795
Publication URI: http://europepmc.org/abstract/MED/39228795
Type: Journal Article/Review
Volume: 17
Parent Publication: Frontiers in molecular neuroscience
ISSN: 1662-5099